With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Modeling H3 G34R and BCOR-Altered Glioma Pathogenesis Using Neural Stem Cells||The Johns Hopkins University School of Medicine / Satoshi Nakata, MD/PhD||Young Investigator Grants||2019||Maryland|
|The Impact of Hypoxia on Epigenetic Changes in Neuroblastoma||University of Chicago / Sakshi Uppal, PhD||Young Investigator Grants||2017||Illinois|
|Exploiting the Potential of Bromodomain Inhibitors in Ewing Sarcoma||Seattle Children's Hospital / Shireen Ganapathi, MD||Young Investigator Grants||2021||Washington|
|Multifunctional Nanomaterials for the Prevention of Radiotherapy's Side Effects and Childhood Cancers||Massachusetts General Hospital / Charalambos Kaittanis, PhD||Young Investigator Grants||2013||Massachusetts|
|Role of N6-Methyladenosine (m6A) mRNA Modification Pathway in Neuroblastoma||Boston Children's Hospital / Shuibin Lin, PhD||Young Investigator Grants||2017||Massachusetts|
|Screening for New Rhabdomyosaroma Pathogenesis Genes in a Drosophila Model||University of Texas Southwestern Medical Center / Kathleen Galindo||Young Investigator Grants||2012||Texas|
|The Role of DEF and SSU Processome in Neuroblastoma Pathogenesis||Dana-Farber Cancer Institute / Ting Tao, PhD||Young Investigator Grants||2015||Massachusetts|
|Therapeutic Targeting of Childhood Leukemia by Pharmacological Inhibition of Proteolytic Cleavage of MLL1||Northwestern University (Illinois) / Zibo Zhao, PhD||Young Investigator Grants||2018||Illinois|
|The Cebpa Downstream Enhancer as a Key Target of Transformation to Acute Myeloid Leukemia||The Johns Hopkins University School of Medicine / Stacy Cooper, MD||Young Investigator Grants||2015||Maryland|
|Molecular Basis of ALK Inhibition Resistance in High-risk Neuroblastoma||Dana-Farber Cancer Institute / David Debruyne, PhD||Young Investigator Grants||2016||Massachusetts|